Middle East & Africa Neurorehabilitation Devices Market

The Middle East & Africa neurorehabilitation devices market was valued at US$ 32.50 million in 2023 and is expected to reach US$ 64.28 million by 2031; it is estimated to register a CAGR of 8.9% from 2023 to 2031.

Technological Advancements Bolster Middle East & Africa Neurorehabilitation Devices Market

Technological advancements in neurorehabilitation devices are improving patient outcomes, safety, and the overall efficiency of neurological disease management. Neurolutions Inc., a Washington University startup company, developed a device called the IpsiHand Upper Extremity Rehabilitation System, which helps people disabled by stroke regain control over their arm and hand function by using their minds. In April 2021, the company received market authorization from the Food and Drug Administration (FDA) for its IpsiHand Upper Extremity Rehabilitation System, which leverages brain-computer interface (BCI) technology licensed by the university. In April 2024, India-based K Physio and Rehab Clinic announced the launch of the ground-breaking Advanced Exoskeletal Neuro Device, revolutionizing neurorehabilitation. The device provides faster recovery for fully and partially paralyzed patients. In February 2023, MindMaze announced the US and EU launch of Izar, a "first-of-its-kind" US FDA-listed and CE-marked smart device for patients with impairment in hand motor function. The device is one of the most effective hand dexterity and strength treatments used in a wide range of neurological conditions.

Such technological developments are likely to bring new trends in the market during the forecast period.

Middle East & Africa Neurorehabilitation Devices Market Overview

The Middle East & Africa neurorehabilitation devices market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa and Saudi Arabia hold the largest market share. As per the "Rights and Wellbeing of Older Persons in Saudi Arabia" report, the number of people aged 60 or more is predicted to increase five-fold from 2020 to 2050, rising from 2 million (5.9% of the total population) to 10.5 million (23.7% of the population). Also, the number of people aged 80 or more is expected to reach 1.6 million, i.e., 4% of the total population by 2050. The prevalence rate of neurological diseases is high among older adults. As per an article titled "Assessing the perception of Parkinson's disease in Al-Ahsa, Saudi Arabia among the visitors of a public campaign: before and after survey," published in April 2024, the prevalence of Parkinson's disease (PD) in Saudi Arabia has been estimated to be 27 per 100,000 population. With aging, the likelihood of developing neurodegenerative conditions increases among people. This necessitates a robust rehabilitation framework to address the unique challenges faced by these individuals, including mobility issues, balance problems, and cognitive decline. Neurorehabilitation devices play a crucial role in improving the quality of life for people suffering from PD. These devices can assist with physical therapy, improve motor skills, and provide cognitive training.

Middle East & Africa Neurorehabilitation Devices Market Revenue and Forecast to 2031 (US$ Million)

Middle East & Africa Neurorehabilitation Devices Strategic Insights

Strategic insights for the Middle East & Africa Neurorehabilitation Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Neurorehabilitation Devices Report Scope

Middle East & Africa Neurorehabilitation Devices Regional Insights

The geographic scope of the Middle East & Africa Neurorehabilitation Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Neurorehabilitation Devices Market Segmentation

The Middle East & Africa neurorehabilitation devices market is categorized into product type, application, end user, and country.

By product type, the Middle East & Africa neurorehabilitation devices market is segmented into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the Middle East & Africa neurorehabilitation devices market share in 2023.

In terms of application, the Middle East & Africa neurorehabilitation devices market is segmented into stroke, traumatic brain injury, spinal cord injury, parkinson's disease, cerebral palsy, and others. The stroke segment held the largest share of the Middle East & Africa neurorehabilitation devices market share in 2023.

By end user, the Middle East & Africa neurorehabilitation devices market is segmented into rehabilitation centers, hospitals & clinics, and home care. The hospitals & clinics segment held the largest share of the Middle East & Africa neurorehabilitation devices market share in 2023.

Based on country, the Middle East & Africa neurorehabilitation devices market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia segment held the largest share of Middle East & Africa neurorehabilitation devices Market in 2023.

Abbott Laboratories; BIONIK; BioXtreme Ltd; Blackrock Microsystems Inc; Ekso Bionics Holdings Inc; EMOTIV; Hocoma AG; Medtronic Plc; Renishaw Plc; and Tyromotion GmbH are some of the leading companies operating in the Middle East & Africa neurorehabilitation devices market.